These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 1376595)

  • 1. Antiretroviral therapy: reverse transcriptase inhibition.
    Connolly KJ; Hammer SM
    Antimicrob Agents Chemother; 1992 Feb; 36(2):245-54. PubMed ID: 1376595
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiretroviral drug resistance: mechanisms, pathogenesis, clinical significance.
    Richman DD
    Adv Exp Med Biol; 1996; 394():383-95. PubMed ID: 8815703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of combination antiretroviral therapy.
    Collier AC
    Adv Exp Med Biol; 1996; 394():355-72. PubMed ID: 8815701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of the avian leukosis-sarcoma complex with 3'-azido-3'-deoxythymidine (AzT); a model for screening and evaluation of chemotherapeutic agents against retrovirus infections].
    Kavsan VM; Rudenko NK; Shneĭder MA; Kraevskiĭ AA; Bibilashvili RSh
    Dokl Akad Nauk SSSR; 1987; 296(6):1492-7. PubMed ID: 2448108
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunologic issues in anti-retroviral therapy.
    Yarchoan R; Mitsuya H; Broder S
    Immunol Today; 1990 Sep; 11(9):327-33. PubMed ID: 1698379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral efficacy of Imexon in the Rauscher murine retrovirus AIDS model.
    Chirigos MA; Ussery MA; Rankin JT; Herrmann D; Bicker U; Black PL
    Immunopharmacol Immunotoxicol; 1990; 12(1):1-21. PubMed ID: 1693633
    [No Abstract]   [Full Text] [Related]  

  • 7. The Seventh Conference on Retroviruses and Opportunistic Infections.
    Merrick S; Gulick R; Boyle B
    AIDS Read; 2000 Mar; 10(3):135-9. PubMed ID: 10758009
    [No Abstract]   [Full Text] [Related]  

  • 8. Quick reference guide to antiretrovirals.
    Schütz M
    Eur J Med Res; 2001 May; 6(5):219-27. PubMed ID: 11410404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral drug development and clinical pharmacology.
    Balis FM; Blaney SM; Poplack DG
    Pediatr Infect Dis J; 1991 Nov; 10(11):849-57. PubMed ID: 1661004
    [No Abstract]   [Full Text] [Related]  

  • 10. [The role of stavudine in antiretroviral therapy].
    Molina JM
    Presse Med; 1998 Oct; 27(33):1708-9. PubMed ID: 9834791
    [No Abstract]   [Full Text] [Related]  

  • 11. New initiatives in combination antiretroviral chemotherapy.
    Rooney JF; Warwick JC; Elkins MM; St Clair MH; Barry DW
    Adv Exp Med Biol; 1996; 394():373-82. PubMed ID: 8815702
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiretroviral treatment: are we entering or exiting the tunnel?].
    Gatell JM; Miró JM
    Med Clin (Barc); 1995 Apr; 104(16):622-5. PubMed ID: 7752715
    [No Abstract]   [Full Text] [Related]  

  • 13. Acyclic nucleoside phosphonates: a new dimension to the chemotherapy of DNA virus and retrovirus infections.
    De Clercq E
    J Med Microbiol; 1998 Jan; 47(1):1-3. PubMed ID: 9449944
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiretroviral drugs].
    Barini O
    Rev Assoc Med Bras (1992); 2001; 47(3):195-6. PubMed ID: 11723497
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of antiretroviral therapy in children and pregnant women.
    McKinney RE
    Adv Exp Med Biol; 1996; 394():345-54. PubMed ID: 8815700
    [No Abstract]   [Full Text] [Related]  

  • 16. Feline immunodeficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndrome.
    North TW; North GL; Pedersen NC
    Antimicrob Agents Chemother; 1989 Jun; 33(6):915-9. PubMed ID: 2475068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different origin of adipogenic stem cells influences the response to antiretroviral drugs.
    Gibellini L; De Biasi S; Nasi M; Carnevale G; Pisciotta A; Bianchini E; Bartolomeo R; Polo M; De Pol A; Pinti M; Cossarizza A
    Exp Cell Res; 2015 Oct; 337(2):160-9. PubMed ID: 26238601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiretroviral treatment and resistance].
    Gómez-Cano M; Villalba N; Mas A; Holguín A; Soriano V
    Rev Clin Esp; 1997 Aug; 197(8):574-82. PubMed ID: 9312796
    [No Abstract]   [Full Text] [Related]  

  • 19. T-cell activation: a cellular target for antiretroviral therapy.
    Fidler S; Weber J
    Eur J Clin Invest; 2000 Feb; 30(2):95-8. PubMed ID: 10651832
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of 3'-azido-2',3'-dideoxythymidine on experimental viral infections].
    Shneĭder MA; Rudenko NK; Kavsan VM; Bibilashvili RSh; Kraevskiĭ AA
    Mol Biol (Mosk); 1987; 21(3):837-46. PubMed ID: 2821379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.